Periodic Reporting for period 1 - LTS (LEARNING TO SLEEP: INCREASING HEALTH THROUGH BETTER SLEEP)
Reporting period: 2020-01-01 to 2020-06-30
The core objective of this feasibility assessment was to develop a business plan, that will guide the development of our company. The study also aimed at outlining and scheduling all steps required to close the gap between the current development stage and successful commercialization of Learning to Sleep treatment.
To prepare for market entry, we have conducted market scale-up studies in Germany, France and Spain, estimating the required costs related to technology development, engaging with local therapists and ensuring legal compliance. We have evaluated the European landscape for B2B2C partners in the private sector (private insurers) and searched for the ways of raising the awareness of our treatment in the three selected countries. The analysis of reimbursement trends in Germany, France and Spain helped us to understand these markets better and adapt our strategy accordingly. Through these efforts, we were able to determine the conditions for the future, the successful development of our company.
Overall, this study allowed us to prepare a solid plan, enabling reaching our financial and commercialisation targets, aligned with the overall business development strategy of the company.
- Better overall health since better sleep will positively affect other diseases;
- Higher productivity since bad sleep affects productivity;
- Lower costs for health care.
Until today Learning to Sleep has treated over 2000 patients in Sweden with good results. The societal impact of this is estimated (based on the above) to 12 million euros.